Long-Term Use of Antiperspirant is Associated with a Low Risk of Postoperative Complications in Patients with Axillary Osmidrosis
- PMID: 36339944
- PMCID: PMC9632330
- DOI: 10.2147/CCID.S381380
Long-Term Use of Antiperspirant is Associated with a Low Risk of Postoperative Complications in Patients with Axillary Osmidrosis
Abstract
Purpose: Many patients with axillary osmidrosis (AO) cannot tolerate the local irritation of strong antiperspirants and discontinue AO use within a short time. This study evaluates the effect of long-term antiperspirant use on postoperative complications after osmidrosis surgery.
Patients and methods: A total of 116 females (66 antiperspirant and 50 non-antiperspirant cases) who underwent osmidrosis surgery were retrospectively reviewed. Postoperative complications were compared between the 2 groups.
Results: Patients with long-term antiperspirant use had a lower risk of full-thickness skin necrosis compared with those who did not use antiperspirants (odds ratio [OR] = 0.048, 95% confidence Interval [CI]: 0.006-0.392, p = 0.005). Patients with antiperspirants use also had a lower risk of moderate-to-severe erythema compared to those without antiperspirants use (moderate vs mild erythema: OR = 0.351, 95% CI: 0.129-0.959, p = 0.041; severe vs mild erythema: OR = 0.161, 95% CI: 0.047-0.550, p = 0.004). Patients who used antiperspirants also had a lower risk of severe skin erosion compared to those who did not use antiperspirants (severe vs mild skin erosion: OR = 0.164, 95% CI: 0.037-0.725, p = 0.017). There was a trend of lower risk in moderate skin erosion in patients with antiperspirant use compared to those without antiperspirant use, but it was not statistically significant (moderate vs mild epidermal damage and peeling: OR = 0.406, 95% CI: 0.158-1.043, p = 0.061).
Conclusion: Postoperative complications in patients with AO who undergo osmidrosis surgery are lower in those with a long-term antiperspirant use compared to patients who did not use antiperspirants.
Keywords: antiperspirant; axillary osmidrosis; complications; surgery.
© 2022 Ho et al.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures

Similar articles
-
Comparison of novel aluminium lactate versus aluminium chloride-based antiperspirant in excessive axillary perspiration: First prospective cohort study.Dermatol Ther. 2021 Jul;34(4):e15020. doi: 10.1111/dth.15020. Epub 2021 Jun 29. Dermatol Ther. 2021. PMID: 34085372
-
Human axillary skin condition is improved following incorporation of glycerol into the stratum corneum from an antiperspirant formulation.Arch Dermatol Res. 2017 Nov;309(9):739-748. doi: 10.1007/s00403-017-1771-y. Epub 2017 Sep 9. Arch Dermatol Res. 2017. PMID: 28889318
-
Randomized control trial: evaluating aluminum-based antiperspirant use, axilla skin toxicity, and reported quality of life in women receiving external beam radiotherapy for treatment of Stage 0, I, and II breast cancer.Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e29-34. doi: 10.1016/j.ijrobp.2011.12.006. Int J Radiat Oncol Biol Phys. 2012. PMID: 22516385 Clinical Trial.
-
If exposure to aluminium in antiperspirants presents health risks, its content should be reduced.J Trace Elem Med Biol. 2014 Apr;28(2):147-150. doi: 10.1016/j.jtemb.2013.12.002. Epub 2013 Dec 19. J Trace Elem Med Biol. 2014. PMID: 24418462 Review.
-
Does antiperspirant use increase the risk of aluminium-related disease, including Alzheimer's disease?Mol Med Today. 1998 Mar;4(3):107-9. doi: 10.1016/s1357-4310(98)01209-x. Mol Med Today. 1998. PMID: 9575492 Review.
Cited by
-
Experience of negative pressure fractional microneedle radiofrequency therapy for axillary osmidrosis: a case study.Arch Dermatol Res. 2024 Dec 5;317(1):66. doi: 10.1007/s00403-024-03560-6. Arch Dermatol Res. 2024. PMID: 39636411
References
LinkOut - more resources
Full Text Sources